rss
Ann Rheum Dis 2009;68:318-323 doi:10.1136/ard.2008.088351
  • Recommendations

EULAR recommendations for the management of large vessel vasculitis

  1. C Mukhtyar1,
  2. L Guillevin2,
  3. M C Cid3,
  4. B Dasgupta4,
  5. K de Groot5,
  6. W Gross6,
  7. T Hauser7,
  8. B Hellmich8,
  9. D Jayne9,
  10. C G M Kallenberg10,
  11. P A Merkel11,
  12. H Raspe6,
  13. C Salvarani12,
  14. D G I Scott13,
  15. C Stegeman10,
  16. R Watts14,
  17. K Westman15,
  18. J Witter16,
  19. H Yazici17,
  20. R Luqmani1,
  21. for the European Vasculitis Study Group
  1. 1
    University of Oxford, Oxford, UK
  2. 2
    University of Paris Descartes, Paris, France
  3. 3
    Hospital Clinic, Barcelona, Spain
  4. 4
    Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, UK
  5. 5
    Klinikum Offenbach, Offenbach, Germany
  6. 6
    University Hospital of Schleswig-Holstein, Lübeck, Germany
  7. 7
    University Hospital, Zurich, Switzerland
  8. 8
    Kreiskrankenhaus Plochingen, Plochingen, Germany
  9. 9
    Addenbrooke’s Hospital, Cambridge, UK
  10. 10
    University Medical Centre Groningen, Groningen, The Netherlands
  11. 11
    Boston University School of Medicine, Boston, Massachusetts, USA
  12. 12
    Arcispedale S Maria Nuova, Reggio Emilia, Italy
  13. 13
    Norfolk and Norwich University Hospital Trust, Norwich, UK
  14. 14
    Ipswich Hospital NHS Trust, Ipswich, UK
  15. 15
    Malmo University Hospital, Malmo, Sweden
  16. 16
    US Food and Drug Administration, Rockville, Maryland, USA
  17. 17
    University of Istanbul, Istanbul, Turkey
  1. R Luqmani, Nuffield Orthopaedic Centre, University of Oxford, Windmill Road, Oxford OX3 7LD, UK; raashid.luqmani{at}noc.anglox.nhs.uk
  • Accepted 7 April 2008
  • Published Online First 15 April 2008

Abstract

Objectives: To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis.

Methods: An expert group (10 rheumatologists, 3 nephrologists, 2 immunolgists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search through a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of large vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion.

Results: Seven recommendations were made relating to the assessment, investigation and treatment of patients with large vessel vasculitis. The strength of recommendations was restricted by the low level of evidence and EULAR standardised operating procedures.

Conclusions: On the basis of evidence and expert consensus, management recommendations for large vessel vasculitis have been formulated and are commended for use in everyday clinical practice.

Footnotes

  • Competing interests: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2008.088351v1
    2. 68/3/318 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.